Jesus Adrian Chavez Lopez, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-344-2000 Fax: 928-336-7319 |
Zarine Kamaluddin, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-336-7019 Fax: 928-336-7319 |
Dr. Peter Paul Patterson, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-336-7019 Fax: 928-336-7319 |
Dr. Priya Elsa Skaria, M.D Pathology - Hematology Medicare: Accepting Medicare Assignments Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-336-7019 Fax: 283-367-3199 |
Mr. Victor Manuel Alvarez, MD Pathology - Forensic Pathology Medicare: Medicare Enrolled Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-336-7019 Fax: 928-336-7319 |
News Archive
Asma Elsony led the tuberculosis programme in Sudan at the same time as she took her doctoral degree under the supervision of Professor Gunnar Bjune of the Department of General Practice and Community Medicine, University of Oslo in Norway.
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, announces the release of version 3.7 of its provider portal application, which features new services and system enhancements based on submitter feedback. The release also contains Capario's 5010 submitter testing tool.
More than nine in 10 millennial moms think it's important for their kids to learn about where their food comes from, and more than three-quarters of those moms actively do things with their kids to help learn just that, according to recent findings.
Young parents are calling for better advice to tackle fuel poverty as almost four million children in England live in families that are struggling to pay their energy bills, according to evidence gathered in a new report.
Idera Pharmaceuticals, Inc. announced today the presentation of data from a Phase 1 clinical trial evaluating IMO-2125, a novel immune modulator, in null-responder patients with chronic hepatitis C virus (HCV) infection.
› Verified 5 days ago